Hummock Pharmaceuticals Private Limited

Hummock Pharmaceuticals Private Limited - trading in Bhopal, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U51909MP2018PTC046934 Incorporated 25 October 2018 ROC Gwalior HQ Bhopal, Madhya Pradesh, India
Active Private Limited Company trading MSME · Micro
Revenue · FY 2020
₹22.64 Lakh
Latest filing
Net profit · FY 2020
₹38,269
Net margin 1.7%
EBITDA · FY 2020
₹1.19 Lakh
EBITDA margin 5.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹29.52 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Hummock Pharmaceuticals Private Limited

Data last updated:

Hummock Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 25 October 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2018PTC046934. Its GSTIN is 23AAECH6947E1ZN (Madhya Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Hummock Pharmaceuticals (Opc) Private Limited. It is led by directors Chetan Kumar Kolhe and Rupali Kolhe.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 119 – A Ashoka Garden, Bhopal, Madhya Pradesh, India – 462023.

As per the financials filed for FY 2020, the company reported a revenue of ₹22.64 Lakh. For the same year it recorded a net profit of ₹38,269 (net margin 1.7%) and EBITDA of ₹1.19 Lakh (EBITDA margin 5.2%).

As per MCA filings, the company has open charges of ₹29.52 Lakh on record.

Hummock Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0038741).

Company details

CIN U51909MP2018PTC046934
Registration Number 046934
Incorporation Date 25 October 2018
ROC Gwalior
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-MP-10-0038741

CIN history

Hummock Pharmaceuticals has one previous CIN (Corporate Identification Number): U51909MP2018OPC046934. The current CIN is U51909MP2018PTC046934, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51909MP2018PTC046934Current
U51909MP2018OPC046934Previous

Recognitions & Rankings of Hummock Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-MP-10-0038741

Contact details

Hummock Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    119 – A Ashoka Garden, Bhopal, Madhya Pradesh, India – 462023
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Hummock Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Hummock Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Hummock Pharmaceuticals Private Limited

FY 2020 filings available

Hummock Pharmaceuticals Private Limited reported revenue of ₹22.64 Lakh for FY 2020.

Revenue · FY 2020
₹22.64 Lakh
Net profit · FY 2020
₹38,269 margin 1.7%
EBITDA · FY 2020
₹1.19 Lakh margin 5.2%

Financial Statement Summary

MetricsFY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹22.64 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.19 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹38,269
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19
Profitability
EBITDA Margin5.2%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hummock Pharmaceuticals Private Limited, buy the company report.

Board of directors of Hummock Pharmaceuticals Private Limited

Hummock Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rupali KolheAdditional Director31 Aug 20224 Years 2 MonthsCurrent
Chetan Kumar KolheDirector25 Oct 20188 Years 0 MonthsCurrent

Peer comparison

Hummock Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Muse Healthcare Private Limited₹22.76 Lakh (FY 2025)-19.0%Lucknow, Uttar Pradesh, India
Uniswen Pharmaceuticals Private Limited₹22.76 Lakh (FY 2020)34.0%Pune, Maharashtra, India
Devann Pharmaceuticals Private Limited₹22.75 Lakh (FY 2025)17.0%Agra, Uttar Pradesh, India
Inocta Pharmaceuticals Private Limited₹22.7 Lakh (FY 2025)0.0%Patna, Bihar, India
Emphaatic Pharmaceuticals Private Limited₹22.69 Lakh (FY 2025)0.0%Navi Mumbai, Maharashtra, India
Hummock Pharmaceuticals Private Limitedthis company₹22.64 Lakh (FY 2020)₹38,2691.7%Bhopal, Madhya Pradesh, India
Navante Pharmaceuticals Private Limited₹22.6 Lakh (FY 2025)Vijayawada, Andhra Pradesh, India
Midsun Pharmaceuticals Private Limited₹22.59 Lakh (FY 2025)62.0%Yeshwanthpur, Karnataka, India
Nilesh Pharmachem Private Limited₹22.58 Lakh (FY 2016)-83.0%Mumbai, Maharashtra, India
Rokro Pharma Private Limited₹22.56 Lakh (FY 2025)7247.0%Hyderabad, Telangana, India
Pearl Lifecare Private Limited₹22.56 Lakh (FY 2023)-29.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Hummock Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹29.52 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Sep 2022100624468Others₹29.52 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hummock Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Hummock Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAECH6947E1ZNMadhya PradeshActive19 Mar 2019

To see the full GST registrations and return filing status of Hummock Pharmaceuticals Private Limited, buy the company report.

Recent activity

Hummock Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Rupali Kolhe was appointed as Additional Director on 31 Aug 2022.

Charges
A charge with Others amounted to Rs. 29.52 Lakh with Charge ID 100624468 was registered on 30 Sep 2022.
Appointed
Rupali Kolhe was appointed as Additional Director.
Ceased
Satyendra Singh Raghuwanshi ceased to be Director.
AGM
Hummock Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Filing
Hummock Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Gwalior.
Appointed
Chetan Kumar Kolhe was appointed as Director.
Incorporation
25 Oct 2018
Hummock Pharmaceuticals Private Limited was registered on 25 Oct 2018 with Roc Gwalior & aged 8 years 27 days as per MCA records.

Frequently asked questions

Hummock Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 25 October 2018 (8+ years old) and is registered under CIN U51909MP2018PTC046934.

Hummock Pharmaceuticals has 2 current directors:

The latest financial statements of Hummock Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Hummock Pharmaceuticals is 23AAECH6947E1ZN, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Hummock Pharmaceuticals is U51909MP2018PTC046934. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hummock Pharmaceuticals was incorporated on 25 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Hummock Pharmaceuticals by revenue are Muse Healthcare Private Limited, Uniswen Pharmaceuticals Private Limited, Devann Pharmaceuticals Private Limited, Inocta Pharmaceuticals Private Limited, Emphaatic Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).

Rupali Kolhe was appointed as Additional Director on 31 Aug 2022. Satyendra Singh Raghuwanshi ceased to be Director on 31 Aug 2022. Chetan Kumar Kolhe was appointed as Director on 25 Oct 2018.

Yes, Hummock Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-10-0038741).

The registered office of Hummock Pharmaceuticals is at 119 – A Ashoka Garden, Bhopal, Madhya Pradesh, India – 462023.

Hummock Pharmaceuticals operates in the trading industry, in the specialty segment.